Update information

Update information

July 2017: We have reviewed the evidence and made new recommendations on treating Parkinson's disease symptoms, deep brain stimulation, monitoring and managing impulse control disorders, and palliative care. These recommendations are marked [2017].

We have also made some changes without an evidence review:

  • changes made to clarify the action of a recommendation

  • the timeframe for referral was removed because it was not evidence based.

These recommendations are marked [2006, amended 2017].

Recommendations marked [2006] last had an evidence review in 2006. In some cases minor changes have been made to the wording to bring the language and style up to date, without changing the meaning.

Minor changes since publication

December 2020: We added advice for women who are pregnant or who are planning a pregnancy to recommendations 1.5.2 and 1.5.3, in line with the MHRA safety advice on modafinil.

September 2020: We linked to the NICE guideline on supporting adult carers in recommendation 1.1.4 and incorporated footnotes into the recommendations in line with accessibility requirements.

October 2019: A footnote was added to reflect a change in marketing authorisation status for botulinum neurotoxin type A preparations.

ISBN: 978-1-4731-2530-8

  • National Institute for Health and Care Excellence (NICE)